Freda C. Lewis-Hall, EVP, Medicines Development at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,250 shares at $26.00 ($33K) on 2008-12-11, disclosed to the SEC on 2008-12-12.
Scheduled sale ($32k) by EVP, Medicines Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 152 | $4K | 12.2% |
| 2 | $26.00 | 1,098 | $29K | 87.8% |
| Total | $26.00 avg | 1,250 | $33K | 100% |
| Filing → |
| VRTX | SELL | 2009-03-20 | $36K | — | Filing → |
| VRTX | SELL | 2008-12-22 | $37K | — | Filing → |